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Protocol
AbstrACt
Introduction Clubfoot is a common congenital birth defect, 
with an average prevalence of approximately 1 per 1000 
live births, although this rate is reported to vary among 
different countries around the world. If it remains untreated, 
clubfoot causes permanent disability, limits educational and 
employment opportunities, and personal growth. The aim of 
this systematic review and meta-analysis is to estimate the 
global birth prevalence of congenital clubfoot.
Methods and analysis Electronic databases including 
MEDLINE, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), Embase, Global Health, Latin American 
& Caribben Health Science Literature (LILACS), Maternity and 
Infant Care, Web of Science, Scopus and Google Scholar will 
be searched for observational studies based on predefined 
criteria and only in English language from inception of 
database in 1946 to 10 November 2017. A standard data 
extraction form will be used to extract relevant information 
from included studies. The Joanna Briggs Institute appraisal 
checklist will be used to assess the overall quality of studies 
reporting prevalence. All included studies will be assessed for 
risk of bias using a tool developed specifically for prevalence 
studies. Forest plots will be created to understand the overall 
random effects of pooled estimates with 95% CIs. An I2 test 
will be done for heterogeneity of the results (P>0.05), and to 
identify the source of heterogeneity across studies, subgroup 
or meta-regression will be used to assess the contribution of 
each variable to the overall heterogeneity. A funnel plot will 
be used to identify reporting bias, and sensitivity analysis will 
be used to assess the impact of methodological quality, study 
design, sample size and the impact of missing data.
Ethics and dissemination This review will be conducted 
completely based on published data, so approval from an 
ethics committee or written consent will not be required. 
The results will be disseminated through a peer-reviewed 
publication and relevant conference presentations.
PrOsPErO registration number CRD42016041922.
IntrOduCtIOn 
Clubfoot, also known as congenital talipes 
equinovarus (CTEV), is one of the most 
common structural and visible birth defects 
and is responsible for major disability in 
children.1 2 It may affect either one foot or 
both feet, and is most commonly idiopathic 
CTEV,3 meaning the causes are not known. 
Much less commonly, it can also present as 
syndromic clubfoot which is associated with 
other congenital anomalies. About half of the 
infants with clubfoot have bilateral involve-
ments, and unilateral deformity occurs 
more often on the right side.4 5 Posterome-
dial ankle and foot soft tissue contractures 
deform and displace tarsal anlagen, giving 
rise to characteristic deformities of equinus, 
heel varus, midfoot adductus and cavus. It 
has been found that syndromic CTEV is often 
more severe and more resistant to treatment.6 
If the condition remains untreated, the 
abnormality can lead to long-term functional 
disability, deformity and pain.7 
Context for this review
The majority of children born with club-
foot remain deprived of specialised institu-
tional management, as the formal health 
systems in low-income and middle-income 
strengths and limitations of this study
 ► This study will provide the best evidence on global 
prevalence of clubfoot, including prevalence in 
high-income and low-income and middle-income 
countries.
 ► The results will help us to understand the global 
burden of disability if clubfoot remains untreated.
 ► The results of this review will provide insight that will 
assist in programme implementation implication, 
and will contribute to clubfoot management at a 
policy level.
 ► As this study will report prevalence from studies on 
overall birth defects, there is a possibility that it may 
not represent the true prevalence of clubfoot.
 ► This review may not represent the true population-
based birth prevalence of clubfoot.
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countries (LMICs) often lack trained service providers 
and healthcare provision.8 Often neglected, children 
with clubfoot are considered a burden to their families. 
They fail to get access to education and have other social 
attainments slower than their healthy peers, which may 
ultimately lead to significant poverty.9 Clubfoot has been 
identified as one of the major congenital malformations 
that incurs an immense physical, social and economic 
burden throughout the life course.10 The outcome of 
this study will help policy-makers develop strategic and 
operational guidelines to operate clubfoot treatment with 
optimum efficiency and effectiveness. Therefore, an esti-
mation of the disease’s burden is essential for planning 
country-specific prevention and management responses 
to this public health problem.
birth prevalence
The global prevalence of clubfoot is estimated to be 
between 0.6 and 1.5 per 1000 live births with around 
80% of all clubfoot cases being born in LMICs.11 12 
According to a 2014 estimate by the Global Clubfoot 
Initiative, the prevalence of clubfoot is 1.4 per 1000 
live births in Sweden.13 In Australia, the prevalence 
is higher among the Aboriginal population than the 
Caucasian population, at 3.5 and 1.1 per 1000 live 
births, respectively. The prevalence is 0.76 per 1000 
live births in Philippines and 0.9 per 1000 live births in 
India.14 A study using the pooled data from 10 birth-de-
fect surveillance programmes in the USA showed the 
overall prevalence of clubfoot was 1.29 per 1000 live 
births; 1.38 among non-Hispanic whites, 1.30 among 
Hispanics and 1.14 among non-Hispanic blacks or Afri-
can-Americans.15 Wynne-Davies reported that the rate 
is much lower among Asians at about 0.6 per 1000 live 
births compared with Pacific Islanders at more than 6 
per 1000 live births.16 Another study in Uganda found a 
similar rate of 1.2 per 1000 with a male to female ratio 
of 2.4:1.17 A recent review conducted by Smythe et al18 
revealed that the pooled estimate for clubfoot birth 
prevalence in LMICs according to WHO regions is 1.11 
(0.96 to 1.26) within the Africa region, 1.74 (1.69, 1.80) 
in the Americas, 1.21 (0.73, 1.68) in South-East Asia 
(excluding India), 1.19 (0.96, 1.42) in India, 2.03 (1.54, 
2.53) in Turkey (Europe region), 1.19 (0.98, 1.40) in 
the Eastern Mediterranean region, 0.94 (0.64, 1.24) in 
the West Pacific (excluding China) and 0.51 (0.50, 0.53) 
in China. In LMICs, birth prevalence of clubfoot varies 
between 0.51 and 2.03 per 1000 live births.
Objectives
The aim of this systematic review and meta-analysis is 
to systematically identify, appraise and synthesise the 
evidence to estimate the global birth prevalence of club-
foot. The specific objectives are to estimate birth prev-
alence based on (1) different regions developed for 
Millennium Development Goals (MDGs), (2) high-in-
come countries and LMICs and (3) different ethnicities.
MEthOds And dEsIgn
This systematic review protocol was developed according 
to the recommendations from the ‘CRD’s guidance for 
undertaking reviews in health care’ by Centre for Reviews 
and Dissemination (CRD), University of York19 and will 
be reported according to the established Meta-analysis Of 
Observational Studies in Epidemiology (MOOSE) guide-
lines.20 The selection process of the studies will be based 
on inclusion and exclusion criteria and will be reported 
following the Preferred Reporting Items for Systematic 
Reviews and Meta-analyses Protocols (PRISMA-P) 2015 
flow diagram.21 A systematic search of the literature will 
be conducted based on the proposed search strategy 
and databases. A comprehensive database will be devel-
oped containing all selected articles for synthesis based 





Observational studies including cross-sectional, case–
control, prospective and retrospective cohort studies, 
and different medical databases (clinical records, vital 
statistics data, government surveillance data and reports, 
Centers for Disease Control and Prevention data, popu-
lation censuses and surveys) including birth-defect regis-
tries if they meet the inclusion criteria.
Study settings
Population-based or hospital-based studies.
Study population
The study population will be all live birth children being 
screened for clubfoot. Studies will include a well-defined 
study population and a reliable estimate of the denomi-
nator population. If the birth prevalence is being provided 
without the number of cases in a well-defined population, 
then cases will be determined with the given information.
Outcome
Birth outcome with CTEV.
Outcome measures
Birth prevalence of clubfoot, that is, the number of cases 
of CTEV per 1000 live births. As prevalence and inci-
dence data are often reported as a proportion, so for 
pooling of proportion during meta-analyses, prevalence 
estimates will be transformed to logit to improve their 
statistical properties, and these will then be converted 
back to prevalence.
Date of publication
Studies reporting in the databases covering the period 
from inception of databases in 1946 to 10 November 2017 
will be considered for review.
Language of publications
Only literature published in English will be included.
 on D
ecem









pen: first published as 10.1136/bm





3Ansar A, et al. BMJ Open 2018;8:e019246. doi:10.1136/bmjopen-2017-019246
Open Access
Type of publications
All relevant studies, regardless of publication status, will 
be included in order to avoid publication bias. The inclu-
sion of conference abstracts and interim results will also 
be considered. Study authors will be contacted if full 
study details are required. Data from conference abstracts 
will be carefully considered, to avoid the differences 
between data reported in conference abstracts and their 
corresponding full reports. ‘Partially published research’ 
(conference abstracts) will be classified as ongoing studies 
and will be reviewed.
Exclusion criteria
Study design
Intervention studies (controlled or uncontrolled), prog-
nostic studies that look at associations between prognostic 
factors and subsequent outcomes or complications, ecolog-
ical studies, case series, case reports and qualitative studies.
Publication type
No restrictions on publication type.
Population
The proposed review will exclude studies not reporting 
the prevalence of clubfoot from birth and studies 
where the source of the population is ambiguous and 
information is not provided as to whether all children 
were screened.
search strategy and literature sources
The search strategy will be constructed taking into 
account the ‘PICO’ (population, intervention, compar-
ator and outcome) framework. As mentioned earlier, we 
will only focus on population and outcome as this review 
will report prevalence of clubfoot on reported live births. 
The following approaches will be used to locate relevant 
studies.
Searching electronic databases
The selection of electronic databases for research will 
be focused on the review topic. Lists of databases will 
be accessed from library. MEDLINE, Cumulative Index 
to Nursing and Allied Health Literature (CINAHL), 
Embase, Global Health, Latin American & Caribben 
Health Science Literature (LILACS), Maternity and 
Infant Care, Web of Science, Scopus and Google Scholar 
will be searched to identify relevant studies.
Visually scanning reference lists from relevant studies
Reference lists of papers (both primary studies and 
reviews) that have been identified by the database searches 
will be browsed to identify further studies of interest.
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Hand searching key journals and conference proceedings
Hand searching will be done by scanning the content of 
journals page by page to identify very recent publications 
that may not have been included and indexed by elec-
tronic databases and to include articles from journals that 
are not indexed by electronic databases. The selection 
of journals to hand search will be made by analysing the 
results of the database searches and identifying the jour-
nals that contain the largest number of relevant sources. 
Selecting journals to hand search will be finalised by 
analysing the results of the database searches to identify 
the journals that contain the largest number of relevant 
studies.
Contacting study authors
Study authors will be contacted if a full-text publica-
tion cannot be accessed for free. Topic experts will be 
requested to check the list to identify any known missing 
studies.
Searching relevant internet resources
Published literature will be retrieved by web browsing 
using search engines such as Google and Google Scholar. 
Internet searching will be done to retrieve published 
literature.
Citation searching
Citation searching will involve selecting the key papers 
already identified for inclusion in the review, and then 
searching for articles that have cited these papers.
Constructing search strategy
Search strategies will be designed to be highly sensi-
tive so as many potentially relevant studies as possible 
are retrieved. If the precision of the search strategy is 
increased, all relevant studies will be carefully considered 
so that none are missed. We will be careful not to miss any 
relevant studies if the precision of the search strategy is 
increased after the initial screening search.
In order to construct an effective combination of 
search terms, the review question will be broken down 
into ‘concepts’. Population, intervention, comparator 
and outcome elements from PICO will be used to struc-
ture the search. Since the review will look for incidence 
of clubfoot, and there will be no intervention or compar-
ison, the search strategy will only focus on population and 
outcome. Advice will be sought from the topic experts on 
the review team and advisory group.
search language
The search and selection strategies will be drawn on estab-
lished systematic review methods as outlined by the CRD. 
The preliminary search strategy was developed from the 
MEDLINE (table 1) which will be used for CINAHL, 
Embase, Global Health, LILACS, Maternity and Infant 
Care, Web of Science, Scopus and Google Scholar to 
identify relevant studies. Table 1 shows the basic search 
strategy in Ovid MEDLINE.
documenting the search
The search process will be reported in sufficient detail 
so that it could be rerun at a later date. The search will 
be documented by recording the process and the results 
contemporaneously. All searches, including internet 
searches, hand searching and contact with experts will be 
recorded. The website, uniform resource locator, the date 
searched, any specific sections searched and the search 
terms used will be reported and a citation in EndNote 
will be created.
study selection and data management
Study selection will be conducted in two stages: an initial 
screening of titles and abstracts against the inclusion 
criteria to identify potentially relevant papers followed 
by screening of the full papers that were identified as 
possibly relevant in the initial screening. Two researchers 
(AA and MM) will screen titles and abstracts and then full 
papers, and there will be a third reviewer in case of any 
disagreement on selection. In case of disagreement, the 
two reviewers will sit together to resolve the disagreement 
between themselves. If a consensus cannot be reached, a 
third reviewer (AER) will be involved. The third reviewer 
will screen the title/abstract/paper against the inclusion 
and exclusion criteria about study eligibility.
Table 1 Search strategy used in Ovid MEDLINE from 
inception of database in 1946 to 10 November 2017
Number Search terms Results
1 Clubfoot/ 3708
2 (Clubf??t or club-f??t).mp. 4379
3 (talipes adj2 equinovarus).mp. 663
4 (talipes adj2 equino-varus).mp. 44
5 pie torcido*.mp. 0
6 1 or 2 or 3 or 4 or 5 4583
7 incidence/or prevalence/ 487 648
8 exp Medical Records/ 139 693
9 exp Population Surveillance/ 65 042
10 (inciden* or prevalen* or occurrence* 
or medical record* or health record* 
or surveillance* or frequency*).mp.
2 483 556
11 7 or 8 or 9 or 10 2 510 094
12 6 and 11 500
13 exp Lower Extremity Deformities, 
Congenital/
9499
14 ((lower limb* or foot* or feet*) adj3 
(defect* or malform* or abnormalit*)).
mp.
1667
15 13 or 14 10 715
16 11 and 15 1005
17 12 or 16 1151
Note. This search strategy will be checked for MeSH term and 
used for other electronic databases.
MeSH, Medical Subject Headings.
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The selection of studies from electronic databases will 
be conducted in two stages.
Stage 1
Decision to include an article will be based on titles, 
source of the article (where available) and abstracts. Arti-
cles will be assessed against the predetermined inclusion 
criteria. If an article does not meet the inclusion criteria, 
then it will be rejected right away. The decision will be 
made based on the agreement of the reviewers. If there 
is any disagreement between the two reviewers (AA and 
MM), the third reviewer will be involved for decision 
(AER). We might allow overinclusion during this first 
stage. Rejected citations will be classified into two main 
categories; those that are clearly not relevant and those 
that address the topic of interest but fail on one or more 
criteria. The first category will be recorded as an irrel-
evant study, with the reason being listed as ‘irrelevant’. 
The second category will be recorded as a study that is 
excluded, and the specific reason for it not meeting the 
inclusion criteria will be recorded. This will increase 
the transparency of the selection process. The selection 
process for the review will be explained in the flow chart 
(figure 1) which will be adopted from the PRISMA study 
flow diagram of study-selection process.
Stage 2
For studies that appear to meet the inclusion criteria, or 
in cases where a definite decision cannot be made based 
on the title and/or abstract of studies alone, the full paper 
will be obtained for detailed assessment against the inclu-
sion and exclusion criteria. Direct access to full papers 
will be explored during hand searching of journals or by 
contacting the authors. To increase the reliability of the 
decision-making process and to ensure reproducibility, all 
papers will be independently assessed by two researchers 
(AA and MM).
Piloting the study selection process
The selection process will be piloted by applying the 
inclusion criteria to a sample of papers in order to check 
that they can be reliably interpreted and that the studies 
are classified appropriately (according to stages 1 and 2 
mentioned earlier). The pilot phase will be used to refine 
and clarify the inclusion criteria and ensure that the 
criteria can be applied consistently by the two researchers 
(AA and MM). Piloting will also give an indication of the 
likely time needed for the full selection process.
blinding
The assessment by two independent researchers will be 
non-blinded.
dealing with duplication
Duplicate publications of research results will be looked 
for to ensure they are not treated as separate studies in 
the review. When multiple reports of a single study are 
identified, they will be treated as a single study but refer-
ence will be made to all the publications.
data extraction
One of two reviewers (AA and MM) using predefined 
data extraction sheets adopted from Cochrane Public 
Health Group Data Extraction and Assessment Template22 
will extract relevant information from included studies 
(online supplementary file 1). The extracted data will 
include information on the study (eg, year of conduct, 
journal name, title of the study, authors name, year of 
publication, country of conduct, design, study setting, 
sample size and study quality items) and outcomes 
(birth). Any missing statistical parameters of importance 
(eg, incidence proportion or cumulative incidence, and 
incidence rate) and variability measures (eg, 95% CIs, 
P values) will be calculated, if data permits, or authors 
of the primary studies will be contacted. All calculated or 
derived data will be denoted as ‘calculated’ and will be 
incorporated in the extraction sheets. The data extracted 
will be cross-checked. Any disagreements regarding the 
extracted data will be resolved between the two reviewers 
or through a consensus or adjudication of a third 
reviewer, if needed. Data extraction forms will be piloted 
on a sample of included studies to ensure that all the rele-
vant information is captured, and that resources are not 
wasted on extracting data which are not required.
study quality and risk of bias assessment
The methodological quality of included studies will be 
appraised by two independent reviewers (AA and MM). 
Quality will be assessed considering the appropriateness 
of the study design to the research objective, risk of bias, 
choice of outcome measure, quality of reporting and 
generalisability. We will define study quality primarily in 
relation to a study’s internal validity, although we will also 
note how other types of validity—statistical conclusion 
validity, construct validity and external validity—are rele-
vant to the study quality assessment in the context of the 
proposed systematic review.
The quality appraisals will be cross-checked, and any 
disagreements will be resolved by a consensus-based 
discussion or through a third reviewer, if necessary. The 
Joanna Briggs Institute (JBI) appraisal checklist will be 
used to assess the overall quality of studies reporting prev-
alence (online supplementary file 2).23 24
data analysis and synthesis
Narrative synthesis
A descriptive summary with data tables will be produced 
to summarise the literature. Both a narrative synthesis 
and, where possible, a quantitative analysis of the data will 
be presented. For narrative synthesis, we will use ‘Guid-
ance on the Conduct of Narrative Synthesis in Systematic 
Reviews’.25 Studies will be clustered according to design 
and setting (hospital  based and population based). 
After the studies have been grouped into common clus-
ters, their characteristics (including their specific design 
and study details and a description of the number and 
characteristics of the study participants included) will be 
presented in summary tables. The evidence for prevalence 
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of clubfoot will be presented separately according to 
regional variation. The regions will be based on low-in-




In the meta-analysis, pooled prevalence of clubfoot on 
a global scale will be assessed using the well-established 
inverse variance-weighted method. The score CI will be 
constructed for individual estimates, which outperforms 
the Wald and exact CIs even in small samples.27 28 The 
pooled CI will be constructed after applying the variance 
stabilising transformation of the proportions for achieving 
the asymptotic normality of the estimate. This will allow us 
to calculate the Wald CI for the pooled estimate. The anal-
ysis will be carried out using Stata V.14.0 (StataCorp).
Test of heterogeneity
To assess heterogeneity of the event rates across studies, 
we will use the Q-statistic test and the I2 statistic. If the test 
for heterogeneity denoted as I2 (if I2≤25%), studies will 
be considered homogeneous.29
Subgroup analysis
Stratified prevalence will be generated by the economic 
levels of the high-income countries and LMICs, by 
sampling methods (random and convenience sampling), 
by type of questionnaires used (validated and non-vali-
dated) and ethnicity.
Assessment of publication bias
To address the publication bias, we will use a contour-en-
hanced funnel plot and a statistical test for asymmetry. 
To address reviewer selection bias, we will seek individual 
participant’s data where possible to examine additional 
heterogeneity between trials.30
Sensitivity analysis
We will conduct a sensitivity analysis to assess the impact 
of methodological quality, study design, sample size, 
effect of missing data and geographical variations, aeti-
ology of idiopathic and syndromic clubfoot, as well as 
the analysis methods of the review results. To investigate 
the suspected asymmetry of the funnel plot due to publi-
cation bias, we will also conduct sensitivity analyses.
dIsCussIOn
This systematic review will identify and summarise the 
relevant evidence on the burden of clubfoot in terms of 
birth prevalence. Strengths and limitations (eg, exclu-
sion of non-English studies, inclusion of conference 
abstracts, etc) of the review will be discussed and gaps 
in the evidence will also be highlighted. The findings 
of this review and those of other similar reviews will be 
compared (if identified) for the degree of consistency.
Secondary analysis of data has been shown to be helpful 
in describing the epidemiology of clinical conditions. The 
estimates generated through analysis of secondary data 
is considered more reliable if the data is validated and 
linked across a registry system (primary-care and second-
ary-care sectors). Such validation work needs prioritisa-
tion. This review will aid in providing a pulled estimate 
of clubfoot prevalence, and also the burden of this birth 
defect globally.
Since we have decided to limit our search to English 
language publications, we may miss relevant articles 
which are published in other languages. However, due 
to the major shift towards the publication of studies in 
English, the extent and effects of language bias may have 
recently been reduced.31
Presenting and reporting of results
The proposed conceptual framework will be guided by the 
systematic review and meta-analysis. The results of the study 
will be reported as per MOOSE guidelines and findings of 
the search strategy as per PRISMA-P flow diagram.
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